William Weber, MD
Sleep Medicine · Summit, NJNPI 1649410481
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $556 of the $746 with a category attached, or 74.6%. 8 manufacturers reported payments, led by Jazz Pharmaceuticals Inc. at 39.0% of the total. That places this record below the midpoint for sleep medicine clinicians in NJ, where the typical reported total is $1,341.
Across 27 payments — averaging $27.61 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Jazz Pharmaceuticals Inc.$291
- Inspire Medical Systems, Inc.$252
- Resmed Corp$90
- Boehringer Ingelheim$46
- Merck$30
- Eisai Inc.$12
- plus $24 from 2 others
What the payments were for
- Food & beverage$55675%
- Education$19025%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Jazz Pharmaceuticals Inc. | 14 | $291 |
| Inspire Medical Systems, Inc. | 4 | $252 |
| Resmed Corp | 1 | $90 |
| Boehringer Ingelheim | 3 | $46 |
| Merck | 2 | $30 |
| Eisai Inc. | 1 | $12 |
| Regeneron Healthcare Solutions, Inc. | 1 | $12 |
| GSK | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Inspire$144
How this compares
$746 in reported general payments places this provider in the 30th percentile of 40 sleep medicine providers in New Jersey.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Zolpidem Tartrate | 35 | $328 |
| Clonazepam | 34 | $270 |
| Trazodone Hcl | 38 | $208 |
| Gabapentin | 30 | $162 |
| Eszopiclone | 13 | $137 |
| Alprazolam | 12 | $24 |
Paid to pharmacies, not to this prescriber.
Other sleep medicine in Summit
- Federico CerroneSummit$13K
- Archana JayakumarSummit$2K
- Jeffrey NahmiasSummit$451
- Prashant PatelBridgewater$20K
- Nehal MehtaBridgewater$19K
- Thanuja HamiltonMount Laurel$9K
- Jimmy HannaNewark$7K
- Tanuj BhatnagarJersey City$7K
- Bankim ShahBoonton$7K
- Kalpeshkumar PatelOld Bridge$5K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.